Development of a High Throughput Scintillation Proximity Assay for Hepatitis C Virus NS3 Protease That Reduces the Proportion of Competitive Inhibitors Identified
Free accessResearch articleFirst published online June, 2000
Development of a High Throughput Scintillation Proximity Assay for Hepatitis C Virus NS3 Protease That Reduces the Proportion of Competitive Inhibitors Identified
A screening assay has been developed for hepatitis C virus (HCV) NS3 protease using the scintillation proximity assay (SPA) technology. The sequence of the peptide substrate used was taken from the site cleaved by the enzyme in the mature nonstructural protein of HCV. The peptide was biotinylated at the N-terminus and tritiated at the C-terminus so that a decrease in signal was detected as a result of enzyme activity.
IC50 values were calculated for the cleaved product, and it was shown that the value obtained was dependent on the substrate concentration used. The effect of substrate concentration on the inhibition of HCV NS3 protease was further highlighted in a mock screening assay, using colored natural product samples, in which the hit rate was altered by a change in substrate concentration. An increase in substrate concentration reduced the proportion of competitive inhibitors identified. This study highlighted the importance of optimizing the components used in SPA assays in order to obtain an assay format valid for high throughput screening.
References
1.
Choo, Q.L., Kuo, G., Weine, A.J., Overby, L.R., Bradley, D.W., Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science244:359-362.
2.
Kuo, G., Choo, Q.L., Alter, H.J., Gitnick, G.L., Redecker, A.G., Purcell, R.H., Myamura, T., Dienstag, J.L., Alter, M.J., Syevens, C.E., Tagtmeyer, G.E., Bonino, F., Colomb, M., Lee, W.S., Kuo, C., Berger, K., Shister, J.R., Overby, L.R., Bradley, D.W., Houghton, M. (1989). An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science244:362-364.
3.
Janssen, H.L.A., Brouwer, J.T., van der Mast, R.C., Schalm, S.W. (1994). Suicide associated with alfa-interferon therapy for chronic viral hepatitis. J. Hepatol.21:241-243.
4.
Weiland, O. (1994). Interferon therapy in chronic hepatitis C virus infection. FEMS Microbiol. Rev.14:279-288.
5.
Krausslich, H.G., Oroszlan, S., Wimme, E. (1989). Viral Proteinases as Targets for Chemotherapy (Current Communications in Molecular Biology). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
6.
Kato, N., Hijikata, M., Ootsuyama, Y., Nakagawa, M., Ohkoshi, S., Sugimura, T., Shimotohno, K. (1990). Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. U.S.A.87:9524-9528.
7.
Grakoui, A., Wychowski, C., Lin, C., Feinstone, S.M., Rice, C.M. (1993). Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol.67:1385-1395.
8.
Pieroni, L., Santolini, E., Fipaldini, C., Pacini, L., Migliaccio, G., La Monica, N. (1997). In vitro study of the NS2-3 protease of hepatitis C virus. J. Virol.71:6373-6380.
9.
Grakoui, A., McCourt, D.W., Wychowski, C., Feinstone, S.M., Rice, C.M. (1993). Characterisation of the hepatitis C virus-encoded seine proteinase: Determination of proteinase-dependent polyprotein cleavage sites. J. Virol.67:2832-2843.
10.
Failia, C., Tomei, L., De Francesco, R. (1994). Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J. Virol.68:3753-3760.
11.
Sudo, K., Inoue, H., Shimizu, Y., Yamaji, K., Konno, K., Shigeta, S., Kaneko, T., Yokota, T., Shimitohno, K. (1996). Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography. Antiviral Res.32:9-18.
12.
Cerretani, M., Di Renzo, L., Serafini, S., Vitelli, A., Gennari, N., Bianchi, E., Pessi, A., Urbani, A., Colloca, S., De Francesco, R., Steinkuhler, C., Altamura, S. (1999). A high-throughput radiometric assay for hepatitis C virus NS3 protease. Anal. Biochem.266:192-197.
13.
De Francesco, R., Urbani, A., Chiara Nardi, M., Tomei, L., Steinktihler, C., Tramontano, A. (1996). A zinc binding site in viral seine proteinases. Biochemistry35:13282-13287.
14.
Steinkuhiler, C., Biasiol, G., Brunetti, M., Urbani, A., Koch, U., Cortses, R., Pessi, A., De Francesco, R. (1998). Product inhibition of the hepatitis C virus NS3 protease. Biochemistry37:8899-8905.
15.
Spencer-Fry, J.E., Brophy, G., O'Beirne, G., Cook, N.D. (1997). Kinetic characterisation of p34cdc2/cyclin B kinase-mediated phosphorylation of peptides derived from histone H1 using phosphocellulose filter binding and scintillation proximity assays. J. Biomol. Screen.2:25.
16.
Steinkuhler, C., Urbani, A., Tomei, L., Biasiol, G., Sardana, M., Bianchi, E., Pessi, A., De Franesco, R. (1996). Activity of purified hepatitis C virus protease NS3 on peptide substrates. J. Virol.70:6694-6700.
17.
Sali, D.L., Ingram, R., Wendel, M., Gupta, D., MaNemar, C., Tsarbopoulos, A., Chen, J.W., Hong, Z., Chase, R., Risano, C., Zhang, R., Yao, N., Kwong, A.D., Ramanathan, L., Le, H.V., Weber, P.C. (1998). Seine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex. Biochemistry37:3392-3401.
18.
Taliani, M., Bianchi, E., Najres, F., Fossatelli, M., Urbani, A., Steinkifhler, C., Defrancesco, R., Pessi, A. (1996). A continuous assay of hepatitis C protease based on resonance energy transfer depsipeptide substrates. Anal. Biochem.240:60-67.
